NPs Basic Information
|
Name |
(12R)-12-Hydroxymonocerin
|
| Molecular Formula | C16H20O7 | |
| IUPAC Name* |
(2S,3aR,9bR)-6-hydroxy-2-[(2R)-2-hydroxypropyl]-7,8-dimethoxy-2,3,3a,9b-tetrahydrofuro[3,2-c]isochromen-5-one
|
|
| SMILES |
C[C@H](C[C@H]1C[C@@H]2[C@H](O1)C3=CC(=C(C(=C3C(=O)O2)O)OC)OC)O
|
|
| InChI |
InChI=1S/C16H20O7/c1-7(17)4-8-5-11-14(22-8)9-6-10(20-2)15(21-3)13(18)12(9)16(19)23-11/h6-8,11,14,17-18H,4-5H2,1-3H3/t7-,8+,11-,14-/m1/s1
|
|
| InChIKey |
OAWLQCWPKLOBPA-PCAXDNMNSA-N
|
|
| Synonyms |
(12R)-12-Hydroxymonocerin; 12?alpha?hydroxymonocerin; CHEMBL488514
|
|
| CAS | NA | |
| PubChem CID | 24896700 | |
| ChEMBL ID | CHEMBL488514 |
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 324.32 | ALogp: | 1.7 |
| HBD: | 2 | HBA: | 7 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 94.4 | Aromatic Rings: | 3 |
| Heavy Atoms: | 23 | QED Weighted: | 0.819 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -5.205 | MDCK Permeability: | 0.00003650 |
| Pgp-inhibitor: | 0.03 | Pgp-substrate: | 0.077 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.003 |
| 30% Bioavailability (F30%): | 0.002 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.813 | Plasma Protein Binding (PPB): | 59.45% |
| Volume Distribution (VD): | 0.92 | Fu: | 18.04% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.109 | CYP1A2-substrate: | 0.726 |
| CYP2C19-inhibitor: | 0.055 | CYP2C19-substrate: | 0.874 |
| CYP2C9-inhibitor: | 0.11 | CYP2C9-substrate: | 0.788 |
| CYP2D6-inhibitor: | 0.013 | CYP2D6-substrate: | 0.343 |
| CYP3A4-inhibitor: | 0.249 | CYP3A4-substrate: | 0.423 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 6.183 | Half-life (T1/2): | 0.531 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.034 | Human Hepatotoxicity (H-HT): | 0.634 |
| Drug-inuced Liver Injury (DILI): | 0.756 | AMES Toxicity: | 0.226 |
| Rat Oral Acute Toxicity: | 0.127 | Maximum Recommended Daily Dose: | 0.931 |
| Skin Sensitization: | 0.444 | Carcinogencity: | 0.685 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.085 |
| Respiratory Toxicity: | 0.774 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005388 |  |
1.000 | D0L1JW |  |
0.312 | ||
| ENC003801 |  |
0.771 | D04TDQ |  |
0.298 | ||
| ENC003612 |  |
0.771 | D09PJX |  |
0.296 | ||
| ENC002527 |  |
0.750 | D0D4HN |  |
0.276 | ||
| ENC003791 |  |
0.750 | D0F7CS |  |
0.272 | ||
| ENC003705 |  |
0.750 | D06GCK |  |
0.269 | ||
| ENC003205 |  |
0.613 | D02LZB |  |
0.255 | ||
| ENC005556 |  |
0.563 | D0G4KG |  |
0.247 | ||
| ENC005907 |  |
0.461 | D09DHY |  |
0.243 | ||
| ENC004992 |  |
0.423 | D0C1SF |  |
0.243 | ||